Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andreas Røder

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Prostate Cancer|November 19, 2011
First danish single-institution experience with radical prostatectomy: biochemical outcome in 1200 consecutive patientsM Andreas Røder, Kasper D Berg, Lisa Gruschy, et al.
Scandinavian Journal of Urology|November 4, 2014
Active surveillance for localized prostate cancer: an analysis of patient contacts and utilization of healthcare resourcesFrederik B Thomsen, Kasper D Berg, M Andreas Røder, et al.
Journal of Surgical Oncology|March 11, 2014
Active surveillance for clinically localized prostate cancer--a systematic reviewFrederik B Thomsen, Klaus Brasso, Laurence H Klotz, et al.
The Lancet. Oncology|January 18, 2017
Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based studyNina Klemann, M Andreas Røder, J Thomas Helgstrand, et al.
European Urology|March 18, 2014
ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancerKasper Drimer Berg, Ben Vainer, Frederik Birkebæk Thomsen, et al.
Journal of Clinical Pathology|June 11, 2015
ERG protein expression over time: from diagnostic biopsies to radical prostatectomy specimens in clinically localised prostate cancerKasper Drimer Berg, Klaus Brasso, Frederik Birkebæk Thomsen, et al.
Clinical Genitourinary Cancer|June 15, 2019
Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate CancerFrederik B Thomsen, M Andreas Røder, Henrik Jakobsen, et al.
BMJ (Clinical Research Ed.)|January 12, 2018
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohortsTyler M Seibert, Chun Chieh Fan, Yunpeng Wang, et al.
Nature Genetics|July 12, 2011
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association studyZsofia Kote-Jarai, Ali Amin Al Olama, Graham G Giles, et al.
Human Molecular Genetics|October 16, 2012
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive diseaseAli Amin Al Olama, Zsofia Kote-Jarai, Fredrick R Schumacher, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Prostate Cancer|November 19, 2011
First danish single-institution experience with radical prostatectomy: biochemical outcome in 1200 consecutive patientsM Andreas Røder, Kasper D Berg, Lisa Gruschy, et al.
Scandinavian Journal of Urology|November 4, 2014
Active surveillance for localized prostate cancer: an analysis of patient contacts and utilization of healthcare resourcesFrederik B Thomsen, Kasper D Berg, M Andreas Røder, et al.
Journal of Surgical Oncology|March 11, 2014
Active surveillance for clinically localized prostate cancer--a systematic reviewFrederik B Thomsen, Klaus Brasso, Laurence H Klotz, et al.
The Lancet. Oncology|January 18, 2017
Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based studyNina Klemann, M Andreas Røder, J Thomas Helgstrand, et al.
European Urology|March 18, 2014
ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancerKasper Drimer Berg, Ben Vainer, Frederik Birkebæk Thomsen, et al.
Journal of Clinical Pathology|June 11, 2015
ERG protein expression over time: from diagnostic biopsies to radical prostatectomy specimens in clinically localised prostate cancerKasper Drimer Berg, Klaus Brasso, Frederik Birkebæk Thomsen, et al.
Clinical Genitourinary Cancer|June 15, 2019
Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate CancerFrederik B Thomsen, M Andreas Røder, Henrik Jakobsen, et al.
BMJ (Clinical Research Ed.)|January 12, 2018
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohortsTyler M Seibert, Chun Chieh Fan, Yunpeng Wang, et al.
Nature Genetics|July 12, 2011
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association studyZsofia Kote-Jarai, Ali Amin Al Olama, Graham G Giles, et al.
Human Molecular Genetics|October 16, 2012
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive diseaseAli Amin Al Olama, Zsofia Kote-Jarai, Fredrick R Schumacher, et al.
Pageof 2